Abstract
It is shown that the clinical efficiency of endonasal specific immunotherapy is extended to all the children with bronchial asthma though it is expressed unequally depending on the mono- or polyetiology of the disease. Higher efficiency of endonasal specific immunotherapy is revealed in mild course of the disease, in monoetiology of bronchial asthma and with pillow allergen. The decrease of intensity of allergologic tests and antivaccinal tests, more pronounced with pillow feather allergen and in repeated courses of the treatment is found at the same time with clinical improvement after endonasal specific immunotherapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
